Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Clinical trial NCT06547489 · RECRUITING
Trial details
- NCT number
- NCT06547489
- Sponsor
- Syndeio Biosciences, Inc
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-03
- Primary completion
- 2027-09-01
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.